ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s share price rose 0.8% during mid-day trading on Friday . The stock traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares were traded during trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Trading Up 0.8%
The firm has a 50 day simple moving average of C$6.50 and a two-hundred day simple moving average of C$6.50. The firm has a market capitalization of C$162.08 million and a P/E ratio of -7.30. The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Read More
- Five stocks we like better than ImmunoPrecise Antibodies
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- How to Invest in Small Cap Stocks
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- Stock Market Sectors: What Are They and How Many Are There?
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
